HSV Dormancy-Undormancy Probe

1 Chida et al. 2009 — Meta-Analysis of Psychosocial Stress and HSV Recurrence

  • Full Citation:: Chida Y, Mao X. Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studies. Brain, Behavior, and Immunity. 2009;23(7):917–925. (Chida and Mao 2009)
  • DOI:: 10.1016/j.bbi.2009.04.009
  • PMID:: 19409481
  • Study Design:: Meta-analysis of prospective studies
  • Sample Size:: 11 articles, 17 psychosocial-disease relationships
  • Key Findings::
    • Robust positive association between psychosocial stress and symptomatic HSV recurrence (r=0.083, 95% CI 0.025–0.141, p=0.005)
    • Psychological distress more strongly associated with recurrence than stress stimuli per se
    • Oral herpes recurrence more strongly stress-associated than genital herpes recurrence
  • Conclusion:: Psychosocial stress is a reliable predictor of HSV recurrence, establishing the stress–reactivation mechanistic link needed for the dormancy-undormancy probe hypothesis.
  • Limitations:: Some indication of publication bias; heterogeneity in stress measurement across studies.
  • Certainty:: 0.53

2 Buchwald et al. 1996 — Viral Serologies in CFS (Null for HSV)

  • Full Citation:: Buchwald D, Ashley RL, Pearlman T, Kith P, Komaroff AL. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. Journal of Medical Virology. 1996;50(1):25–30. (Buchwald et al. 1996)
  • DOI:: 10.1002/(SICI)1096-9071(199609)50:1<25::AID-JMV6>3.0.CO;2-V
  • PMID:: 8890037
  • Study Design:: Cross-sectional serological survey
  • Sample Size:: n=548 chronically fatigued patients vs controls
  • Key Findings::
    • NULL RESULT. No consistent differences in seroprevalence or GMT of antibodies to 13 viruses including HSV-1 and HSV-2
    • No differences across subsets: CFS, fibromyalgia, psychiatric disorders, acute viral onset, documented fever
  • Conclusion:: Standard viral serologies (HSV-1, HSV-2 included) do not distinguish CFS patients from controls. This is the largest negative study for HSV in CFS.
  • Limitations:: 1990s serological methods; cross-sectional design; binary seropositivity thresholds may miss subtle differences.
  • Certainty:: 0.65

3 Koelle et al. 2002 — Discordant Twin Study (Null for HSV)

  • Full Citation:: Koelle DM, Barcy S, Huang ML, Ashley RL, Corey L, Zeh J, Ashton S, Buchwald D. Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome. Clinical Infectious Diseases. 2002;35(5):518–525. (Koelle et al. 2002)
  • DOI:: 10.1086/341774
  • PMID:: 12173124
  • Study Design:: Co-twin control study
  • Sample Size:: 22 monozygotic twin pairs (44 individuals) discordant for CFS
  • Key Findings::
    • NULL RESULT. HSV-1/2 antibodies and PBMC PCR did not differ between CFS and healthy co-twins
    • Comprehensive viral panel (10 viruses; HHV-6/7/8, CMV, EBV, HSV, VZV, JC, BK, Parvovirus B19) all negative
    • Co-twin design controls both genetics and environment
  • Conclusion:: Genetically and environmentally matched design finds no HSV or other herpesvirus marker distinguishing CFS from health. Strongest negative evidence.
  • Limitations:: Small sample (22 pairs); monozygotic twin design may limit generalizability despite strengthening causal inference.
  • Certainty:: 0.55

4 Yu et al. 2018 — Treg Cells Required for HSV-1 Latency and Stress Reactivation

  • Full Citation:: Yu W, Geng S, Suo Y, Wei X, Cai Q, Wu B, Zhou X, Shi Y, Wang B. Critical role of regulatory T cells in the latency and stress-induced reactivation of HSV-1. Cell Reports. 2018;25(9):2379–2389.e3. (Yu et al. 2018)
  • DOI:: 10.1016/j.celrep.2018.10.105
  • PMID:: 30485807
  • Study Design:: Murine experimental model (HSV-1 ocular infection)
  • Sample Size:: Mouse model; ocular route
  • Key Findings::
    • Treg cells required for HSV-1 latency establishment
    • Host stress induces HSV-1 reactivation via increased Treg cell control of CD8+ T cells
    • Diminished immune surveillance during stress permits viral replication
    • Proposes Treg regulation as key therapeutic target for HSV control
  • Conclusion:: Establishes the mechanistic pathway: stress → Treg ↑ → CD8+ T cell ↓ → HSV-1 reactivation. This is the key mechanism for the dormancy-undormancy probe framework.
  • Limitations:: Mouse model; ocular route differs from natural oral/genital infection; translational gap to human HSV recurrence.
  • Certainty:: 0.30

5 Sepúlveda et al. 2019 — Treg-Herpesvirus ME/CFS Hypothesis

  • Full Citation:: Sepúlveda N, Carneiro J, Lacerda E, Nacul L. Myalgic encephalomyelitis/chronic fatigue syndrome as a hyper-regulated immune system driven by an interplay between regulatory T cells and chronic human herpesvirus infections. Frontiers in Immunology. 2019;10:2684. (Sepúlveda et al. 2019)
  • DOI:: 10.3389/fimmu.2019.02684
  • PMID:: 31824487
  • PMCID:: PMC6883905
  • Study Design:: Hypothesis paper + computational model simulation
  • Sample Size:: N/A (simulation study)
  • Key Findings::
    • Treg-mediated chronic immune activation to HSV-1, HHV-6, and EBV could explain ME/CFS pathogenesis
    • Mild infections with high autoimmune potential → persistent inflammation under Treg control → fatigue
    • Computational model reproduces increased Treg density/percentages observed in ME/CFS
  • Conclusion:: Connects Treg dysregulation, chronic herpesvirus activation, and ME/CFS fatigue in a unified mechanistic model that aligns with the HSV dormancy-undormancy probe concept.
  • Limitations:: Theoretical; no empirical validation; simplified CD4+ T-cell repertoire model.
  • Certainty:: 0.50

6 Schreiner et al. 2020 — HHV-6 Reactivation, Mitochondrial Fragmentation, and Antiviral State in ME/CFS

  • Full Citation:: Schreiner P, Harrer T, Scheibenbogen C, Lamer S, Schlosser A, Naviaux RK, Prusty BK. Human herpesvirus-6 reactivation, mitochondrial fragmentation, and the coordination of antiviral and metabolic phenotypes in myalgic encephalomyelitis/chronic fatigue syndrome. ImmunoHorizons. 2020;4(4):201–215. (Schreiner et al. 2020)
  • DOI:: 10.4049/immunohorizons.2000006
  • PMID:: 32327453
  • Study Design:: In vitro + patient serum adoptive transfer
  • Sample Size:: 10 ME/CFS patients (serum) + cell line experiments
  • Key Findings::
    • HHV-6 reactivation causes mitochondrial fragmentation, dUTPase/thymidylate synthase induction, pyruvate dehydrogenase inhibition
    • Serum from 10 ME/CFS patients transfers an antiviral state in A549 cells that blocks HSV-1 and influenza-A superinfection
    • Links herpesvirus reactivation → mitochondrial dysfunction → metabolic collapse
  • Conclusion:: Herpesvirus reactivation in ME/CFS activates cell danger response with antiviral protection at cost of energy metabolism. Directly relevant to HSV probe: ME/CFS serum creates anti-HSV state that may suppress HSV outbreaks, paradoxically.
  • Limitations:: Very small patient sample (n=10); in vitro model; mechanism needs larger cohort validation.
  • Certainty:: 0.44

7 Henderson 2014 — Valacyclovir for Chronic Fatigue in Adolescents

  • Full Citation:: Henderson TA. Valacyclovir treatment of chronic fatigue in adolescents. Advances in Mind-Body Medicine. 2014;28(1):4–14.
  • PMID:: 24445302
  • Study Design:: Clinical case report/series
  • Sample Size:: Small (adolescent chronic fatigue)
  • Key Findings::
    • Valacyclovir treatment associated with improvement in adolescent chronic fatigue
    • Extends herpesvirus-contribution framework to younger patient population
  • Conclusion:: Suggests herpesvirus reactivation may be clinically relevant even in adolescent chronic fatigue, consistent with antiviral-responsive subpopulations.
  • Limitations:: Small sample; no control group; single author; low-tier journal.
  • Certainty:: 0.35

8 Gopinath et al. 2023 — Herpes Labialis Epidemiology Review

  • Full Citation:: Gopinath D, Koe KH, Maharajan MK, Panda S. A comprehensive overview of epidemiology, pathogenesis and the management of herpes labialis. Viruses. 2023;15(1):225. (Gopinath et al. 2023)
  • DOI:: 10.3390/v15010225
  • PMID:: 36680265
  • PMCID:: PMC9867007
  • Study Design:: Comprehensive review
  • Sample Size:: N/A (literature review)
  • Key Findings::
    • HSV-1 global prevalence ~67% in individuals aged <50
    • Recurrence rate: 20–40% of seropositive individuals
    • Known recurrence triggers: UV radiation, psychological stress, fever, menstruation, trauma
  • Conclusion:: Provides essential baseline epidemiology for interpreting HSV outbreak frequency in ME/CFS. Expected recurrence rate 20–40% must be exceeded for outlier PEM-triggered signal.
  • Limitations:: Review; no new empirical data; some regional data bias toward SE Asia.
  • Certainty:: 0.41

9 Schalkwijk et al. 2022 — Acyclovir Resistance Review

  • Full Citation:: Schalkwijk HH, Snoeck R, Andrei G. Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives. Biochemical Pharmacology. 2022;206:115322.
  • DOI:: 10.1016/j.bcp.2022.115322
  • PMID:: 36309081
  • Study Design:: Review
  • Sample Size:: N/A (literature review)
  • Key Findings::
    • Acyclovir resistance in immunocompetent patients: ~0.3%
    • Higher resistance rate in immunocompromised (5–14%)
    • Alternative therapies: foscarnet, cidofovir, helicase-primase inhibitors
  • Conclusion:: Supports long-term safety and low resistance risk of valacyclovir suppressive therapy, relevant for any HSV-suppression protocols in ME/CFS trials.
  • Limitations:: Review; no novel data.
  • Certainty:: 0.41

10 Ariza 2020 — Commentary on Blomberg 2019 Herpesvirus Null Study

  • Full Citation:: Ariza ME. Commentary: Antibodies to human herpesviruses in myalgic encephalomyelitis/chronic fatigue syndrome patients. Frontiers in Immunology. 2020;11:1400.
  • DOI:: 10.3389/fimmu.2020.01400
  • PMID:: 32793195
  • PMCID:: PMC7390837
  • Study Design:: Commentary
  • Sample Size:: N/A
  • Key Findings::
    • Argues Blomberg 2019 multiplex immunoassay may miss conformational epitopes
    • dUTPase antibodies proposed as more specific markers of herpesvirus reactivation in ME/CFS than standard structural/latent antigen serology
  • Conclusion:: Null results in standard herpesvirus serology may reflect antigen choice rather than absence of reactivation. dUTPase-based assays may be more sensitive.
  • Limitations:: Commentary; opinion piece; potential conflict of interest (same research group as dUTPase antibody studies).
  • Certainty:: 0.35

11 Domingues et al. 2021 — Herpesvirus Serology Distinguishes ME/CFS Subgroups

  • Full Citation:: Domingues TD, Grabowska AD, Lee JS, Ameijeiras-Alonso J, Westermeier F, Scheibenbogen C, Cliff JM, Nacul L, Lacerda EM, Mouriño H, Sepúlveda N. Herpesviruses serology distinguishes different subgroups of patients from the United Kingdom myalgic encephalomyelitis/chronic fatigue syndrome biobank. Frontiers in Medicine. 2021;8:686736.
  • DOI:: 10.3389/fmed.2021.686736
  • PMID:: 34291062
  • PMCID:: PMC8287507
  • Study Design:: Re-analysis of serological data with sensitivity analysis
  • Sample Size:: 226 ME/CFS (4 trigger-based subgroups) + 99 healthy controls
  • Key Findings::
    • S3 subgroup (lab-confirmed infection trigger) had lower CMV seroprevalence vs controls
    • Herpesvirus serology distinguished ME/CFS subgroups by disease trigger
    • Associations did not survive Benjamini-Yekutieli multiple-testing correction
  • Conclusion:: Trigger-based ME/CFS subgroups may have different herpesvirus profiles, suggesting heterogeneity that could mask HSV-specific signals in pooled analyses.
  • Limitations:: Re-analysis; arbitrary seropositivity cutoff sensitivity; multiple testing burden limits confidence.
  • Certainty:: 0.55

References

Buchwald, Dedra, Rhoda L Ashley, Terry Pearlman, Phalla Kith, and Anthony L Komaroff. 1996. “Viral Serologies in Patients with Chronic Fatigue and Chronic Fatigue Syndrome.” Journal of Medical Virology 50 (1): 25–30. https://doi.org/10.1002/(SICI)1096-9071(199609)50:1<25::AID-JMV6>3.0.CO;2-V.
Chida, Yoichi, and Xiaoling Mao. 2009. “Does Psychosocial Stress Predict Symptomatic Herpes Simplex Virus Recurrence? A Meta-Analytic Investigation on Prospective Studies.” Brain, Behavior, and Immunity 23 (7): 917–25. https://doi.org/10.1016/j.bbi.2009.04.009.
Gopinath, Divya, Ken Huei Koe, Manoj Kumar Maharajan, and Sujata Panda. 2023. “A Comprehensive Overview of Epidemiology, Pathogenesis and the Management of Herpes Labialis.” Viruses 15 (1): 225. https://doi.org/10.3390/v15010225.
Koelle, David M, Serge Barcy, Meei-Li Huang, Rhoda L Ashley, Lawrence Corey, Judy Zeh, Suzanne Ashton, and Dedra Buchwald. 2002. “Markers of Viral Infection in Monozygotic Twins Discordant for Chronic Fatigue Syndrome.” Clinical Infectious Diseases 35 (5): 518–25. https://doi.org/10.1086/341774.
Schreiner, Philipp, Thomas Harrer, Carmen Scheibenbogen, Stephanie Lamer, Andreas Schlosser, Robert K. Naviaux, and Bhupesh K. Prusty. 2020. “Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.” ImmunoHorizons 4 (4): 201–15. https://doi.org/10.4049/immunohorizons.2000006.
Sepúlveda, Nuno, Jorge Carneiro, Eliana Lacerda, and Luis Nacul. 2019. “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome as a Hyper-Regulated Immune System Driven by an Interplay Between Regulatory t Cells and Chronic Human Herpesvirus Infections.” Frontiers in Immunology 10: 2684. https://doi.org/10.3389/fimmu.2019.02684.
Yu, Wen, Shuang Geng, Yan Suo, Xuejiao Wei, Qing Cai, Ben Wu, Xianzheng Zhou, Yuling Shi, and Baoxiang Wang. 2018. “Critical Role of Regulatory t Cells in the Latency and Stress-Induced Reactivation of HSV-1.” Cell Reports 25 (9): 2379–2389.e3. https://doi.org/10.1016/j.celrep.2018.10.105.